BEGIN:VCALENDAR VERSION:2.0 PRODID:-//wp-events-plugin.com//7.2.3.1//EN TZID:Europe/Helsinki X-WR-TIMEZONE:Europe/Helsinki BEGIN:VEVENT UID:36@inflames.utu.fi DTSTART;TZID=Europe/Helsinki:20201127T121500 DTEND;TZID=Europe/Helsinki:20201127T160000 DTSTAMP:20230120T083146Z URL:https://inflames.utu.fi/events/dissertation-defense-physiology-msc-she yla-cisneros-montalvo/ SUMMARY:Dissertation defense (Physiology): MSc Sheyla Cisneros Montalvo DESCRIPTION:\nMSc Sheyla Cisneros Montalvo defends her dissertation in Phys iology entitled ”Old Acquaintances and new perspectives into testicular development and function”.\n\nYou can follow the dissertation online: ht tps://utu.zoom.us/j/69561849902\n\nOpponent: Associate Professor Serge Nef \, University of Geneva\, Switzerland\nCustos: Professor Jorma Toppari\, U niversity of Turku\n\nDue to the current situation\, only 50 participants are allowed in the lecture hall.\n\nThe University of Turku actively follo ws the coronavirus situation and the authorities’ instructions. The Univ ersity may change the instructions according to the situation.\n END:VEVENT BEGIN:VEVENT UID:3@inflames.utu.fi DTSTART;TZID=Europe/Helsinki:20201203T120000 DTEND;TZID=Europe/Helsinki:20201203T130000 DTSTAMP:20230120T083146Z URL:https://inflames.utu.fi/events/uncovering-novel-mechanisms-of-crosstal k-in-the-tumour-microenvironment/ SUMMARY:Uncovering novel mechanisms of crosstalk in the tumour microenviron ment DESCRIPTION:Uncovering novel mechanisms of crosstalk in the tumour microenv ironment ATTACH;FMTTYPE=image/jpeg:https://inflames.utu.fi/wp-content/uploads/2020/ 12/sahai-400px-300x300-1.jpg END:VEVENT BEGIN:VEVENT UID:9@inflames.utu.fi DTSTART;TZID=Europe/Helsinki:20201204T000000 DTEND;TZID=Europe/Helsinki:20201204T000000 DTSTAMP:20230120T083146Z URL:https://inflames.utu.fi/events/appac-ii/ SUMMARY:APPAC II DESCRIPTION:December 4 2020: Suvi Sippola\, University Of Turku END:VEVENT BEGIN:VEVENT UID:6@inflames.utu.fi DTSTART;TZID=Europe/Helsinki:20201211T120000 DTEND;TZID=Europe/Helsinki:20201211T120000 DTSTAMP:20230120T083146Z URL:https://inflames.utu.fi/events/esmo-io-geneva-switzerland/ SUMMARY:ESMO IO Geneva\, Switzerland DESCRIPTION:December 11 2020: Maija Hollmén gives a an invited talk at ESM O IO Geneva\, Switzerland: The role of myeloid cells in shaping tumor micr oenvironment END:VEVENT BEGIN:VEVENT UID:42@inflames.utu.fi DTSTART;TZID=Europe/Helsinki:20210129T120000 DTEND;TZID=Europe/Helsinki:20210129T160000 DTSTAMP:20230120T083146Z URL:https://inflames.utu.fi/events/dissertation-defense-medical-microbiolo gy-and-immunology-msc-dominik-eichin-2/ SUMMARY:Dissertation defense (Medical Microbiology and Immunology): MSc Dom inik Eichin DESCRIPTION:\n\n\nMSc Dominik Eichin defends his dissertation in Medical Mi crobiology and Immunology entitled ”Immunoregulatory roles of CD73 in ly mphatic endothelial and myeloid cells”.\n\nThe audience can participate in the defence by remote access: https://utu.zoom.us/j/64094084619\n\nOppo nent: Associate Professor Pipsa Saharinen\, University of Helsinki\nCustos : Academician Professor Sirpa Jalkanen\, University of Turku\n\nThe Univer sity of Turku actively follows the coronavirus situation and the authoriti es’ instructions. The University may change the instructions according t o the situation.\n\n\n END:VEVENT BEGIN:VEVENT UID:33@inflames.utu.fi DTSTART;TZID=Europe/Helsinki:20210129T120000 DTEND;TZID=Europe/Helsinki:20210129T160000 DTSTAMP:20230120T083146Z URL:https://inflames.utu.fi/events/dissertation-defense-medical-microbiolo gy-and-immunology-msc-dominik-eichin/ SUMMARY:Dissertation defense (Medical Microbiology and Immunology): MSc Dom inik Eichin DESCRIPTION:\nMSc Dominik Eichin defends his dissertation in Medical Microb iology and Immunology entitled ”Immunoregulatory roles of CD73 in lympha tic endothelial and myeloid cells”.\n\n\n\nThe audience can participate in the defence by remote access: https://utu.zoom.us/j/64094084619\n\nOppo nent: Associate Professor Pipsa Saharinen\, University of Helsinki\nCustos : Academician Professor Sirpa Jalkanen\, University of Turku\n\nThe Univer sity of Turku actively follows the coronavirus situation and the authoriti es’ instructions. The University may change the instructions according t o the situation.\n\n END:VEVENT BEGIN:VEVENT UID:39@inflames.utu.fi DTSTART;TZID=Europe/Helsinki:20210219T081500 DTEND;TZID=Europe/Helsinki:20210219T120000 DTSTAMP:20230120T083146Z URL:https://inflames.utu.fi/events/docentship-lecture-by-phd-rogerio-de-fi gueiredo/ SUMMARY:Docentship lecture by PhD Rogerio De Figueiredo DESCRIPTION:Welcome to join the docentship lecture by PhD Rogerio De Figuei redo\, Academy Research Fellow\, MediCity\, University of Turku Held on Fr iday 19 February at 08:15 via zoom: https://lnkd.in/gypHiEE\nTitle: Princi ples of Immunology\n \;\n\nThe lecture would be for 1st year students of any health sciences related course.\n\n \; END:VEVENT BEGIN:VEVENT UID:45@inflames.utu.fi DTSTART;TZID=Europe/Helsinki:20210219T120000 DTEND;TZID=Europe/Helsinki:20210219T160000 DTSTAMP:20230124T194626Z URL:https://inflames.utu.fi/events/vaitos-kliininen-fysiologia-ja-isotoopp ilaaketiede-fm-riikka-viitanen/ SUMMARY:Väitös (kliininen fysiologia ja isotooppilääketiede): FM Riikka Viitanen DESCRIPTION:FM Riikka Viitanen esittää väitöskirjansa ”Evaluation of 68Ga-labeled PET radiopharmaceuticals for imaging of avß3 integrin and va scular adhesion protein-1 in inflammation and cancer” julkisesti tarkast ettavaksi Turun yliopistossa perjantaina 19.2.2021 klo 12.00.\n\nVäitöst ilaisuutta voi seurata etäyhteyden kautta: https://utu.zoom.us/j/65929013 004\n\nVastaväittäjänä toimii LT Johanna Huhtakangas (Kuopion yliopist ollinen sairaala (KYS)) ja kustoksena professori Anne Roivainen (Turun yli opisto). Tilaisuus on suomenkielinen. Väitöksen alana on kliininen fysio logia ja isotooppilääketiede.\n\nTurun yliopisto seuraa aktiivisesti kor onavirustilannetta ja viranomaisten ohjeita. Yliopisto päivittää ohjeit aan tilanteen mukaan. Ohjeet ja linkit löytyvät osoitteesta: utu.fi/koro navirus ATTACH;FMTTYPE=image/jpeg:https://inflames.utu.fi/wp-content/uploads/2021/ 11/unnamed-file-scaled.jpg END:VEVENT BEGIN:VEVENT UID:15@inflames.utu.fi DTSTART;TZID=Europe/Helsinki:20210311T180000 DTEND;TZID=Europe/Helsinki:20210311T190000 DTSTAMP:20230120T083146Z URL:https://inflames.utu.fi/events/frontiers-of-science-why-so-many-ways-t o-die/ SUMMARY:Frontiers of Science: Why so many ways to die? DESCRIPTION: ATTACH;FMTTYPE=image/jpeg:https://inflames.utu.fi/wp-content/uploads/2021/ 02/dixit-logot-2-1.jpg END:VEVENT BEGIN:VEVENT UID:18@inflames.utu.fi DTSTART;TZID=Europe/Helsinki:20210325T150000 DTEND;TZID=Europe/Helsinki:20210325T160000 DTSTAMP:20230120T083146Z URL:https://inflames.utu.fi/events/frontiers-of-science-allosteric-activat ors-of-protein-phosphatase-2a-display-broad-antitumor-activity/ SUMMARY:Frontiers of Science: Allosteric activators of protein phosphatase 2A display broad antitumor activity DESCRIPTION: ATTACH;FMTTYPE=image/jpeg:https://inflames.utu.fi/wp-content/uploads/2021/ 02/look-logot-2.jpg END:VEVENT BEGIN:VEVENT UID:21@inflames.utu.fi DTSTART;TZID=Europe/Helsinki:20210408T120000 DTEND;TZID=Europe/Helsinki:20210408T130000 DTSTAMP:20230120T083147Z URL:https://inflames.utu.fi/events/frontiers-of-science-the-molecular-chap erone-hsp90/ SUMMARY:Frontiers of Science: The molecular chaperone Hsp90 DESCRIPTION: ATTACH;FMTTYPE=image/jpeg:https://inflames.utu.fi/wp-content/uploads/2021/ 02/picard-logot-2.jpg END:VEVENT BEGIN:VEVENT UID:48@inflames.utu.fi DTSTART;TZID=Europe/Helsinki:20210408T150000 DTEND;TZID=Europe/Helsinki:20210408T163000 DTSTAMP:20230120T083147Z URL:https://inflames.utu.fi/events/welcome-to-the-ex-vivo-models-in-immuno -oncology-research-sebinar/ SUMMARY:Welcome to the “Ex vivo models in immuno-oncology research” seb inar on 8 April 2021 at 15.00-16.30! DESCRIPTION:Cancer IO project\, coordinated by the University of Helsinki\, is starting a bi-monthly sebinar (webinar + seminar) series in April 2021 . The first session focuses on Ex vivo models in immuno-oncology research.  Welcome to join the event on in Zoom. Programme and more information be low and on Cancer IO’s website &\; LinkedIn.\n\nCancer IO Sebinar Series Session I: Ex vivo models in immuno-oncology research \n\n08.04.2 021\, 15:00-16:30 (Helsinki time)\, Zoom event \n\nThis interactive bi- monthly sebinar (seminar + webinar) series aims to bring you the newest developments in the field of immuno-oncology presented by leading scientis ts. Every sebinar will have an important interactive element in the form o f a panel discussion\, where the invited speaker discusses a timely topic with local scientists and clinicians. Sebinar attendants are welcomed to participate in the discussion using the Q&\;A feature.\n\nIn the firs t edition of the Cancer IO Sebinar series (Thursday 8.4.2021\; 15.00-16.3 0) we will hear about the latest development of patient-derived ex vivo  models in an immuno-oncology setting\, and discuss about the possible future use of these models in clinical decision making. Our invited speak ers and panelists are Dr David Barbie from Dana-Farber Cancer Institute &\; Harvard Medical School (biography below)\, Johana Kuncova-Kallio fr om UPM Biomedicals\, Peeter Karihtala from Helsinki University Hospital an d Jeroen Pouwels from University of Helsinki.\n\nProgram: \n\n15:00 - 15: 10 Introduction to ex vivo models\, Jeroen Pouwels / Research Coordinat or in Cancer IO\n\n15:10 - 15:20 3D Solutions &\; tissue preservation\ , Johana Kuncova-Kallio / Director in UPM Biomedicals\n\n15:20 - 16:10 Ex vivo systems incorporating the tumor microenvironment\, Dr. David Barb ie /  Assistant Professor in Dana-Farber Cancer Institute &\; Harvar d Medical School\n\n16:10 - 16:30 Panel discussion: The use of ex vivo cul tures in clinical decision making: Utopia or soon-to-be reality?\n\nPaneli sts: David Barbie\, Johana Kuncova-Kallio\, Jeroen Pouwels and Resea rch Director Peeter Karihtala\, Helsinki University Hospital\n\nSession Ch air: Heidi Haikala\, Cancer IO &\; Dana-Farber Cancer Institute\n\nB iography for Dr. David Barbie: \n\nDr. David A. Barbie is an Assistant Professor of Medicine at Harvard Medical School and Thoracic Oncologist a t the Dana-Farber Cancer Institute\, and an Associate Director of the Belf er Center for Science and International Affairs. He obtained an A.B. from Harvard College in 1997 and M.D. from Harvard Medical School in 2002. Dr.  Barbie was an HHMI Medical Fellow from 1999-2000 between his 2nd and 3 rd years of medical school\, working in Dr. Ed Harlow’s lab at Massachu setts General Hospital. He completed his residency in internal medicine at Massachusetts General Hospital in 2005\, followed by a year as medical ch ief resident in 2006.  Dr. Barbie was a medical oncology fellow in the Dana-Farber/Partners CancerCare program\, which he completed in 2008. Foll owing a post-doctoral fellowship in Dr. William Hahn’s lab at the Broad Institute\, he received a tenure-track independent investigator position i n 2010 at Dana-Farber\, and a clinical position within the Lowe Center for Thoracic Oncology.\n\nRecent selected publications:  \n\n\nDynamic sing le-cell RNA sequencing identifies immunotherapy persister cells following PD-1 blockade. J Clin Invest. 2021  \n\nTumor-Derived cGAMP Regulates A ctivation of the Vasculature. Front Immunol. 2020 \n\nInactivation of F bxw7 Impairs dsRNA Sensing and Confers Resistance to PD-1 Blockade. Canc er Discov. 2020  \n\nTBK1 Activation by VHL Loss in Renal Cell Carcinoma : A Novel HIF-Independent Vulnerability. Cancer Discov. 2020 \n\nUse of  Ex Vivo Patient-Derived Tumor Organotypic Spheroids to Identify Combin ation Therapies for HER2 Mutant Non-Small Cell Lung Cancer. Clin Cancer Res. 2020 \n\nEngineering approaches for studying immune-tumor cell inte ractions and immunotherapy. iScience. 2020 \n\nSuppression of STING Asso ciated with LKB1 Loss in KRAS-Driven Lung Cancer. Cancer Discov. 2019 \n \nDefining T Cell States Associated with Response to Checkpoint Immunother apy in Melanoma. Cell. 2018 \n\nA Cancer Cell Program Promotes T Cell Ex clusion and Resistance to Checkpoint Blockade. Cell. 2018 \n\nEx Vivo P rofiling of PD-1 Blockade Using Organotypic Tumor Spheroids. Cancer Disco v. 2018 Feb\;8(2):196-215. doi: 10.1158/2159-8290.CD-17-0833. Epub 2017 No v 3.PMID: 29101162  \n\nFull publication list: \n\nhttps://pubmed.ncbi .nlm.nih.gov/?term=david+barbie ATTACH;FMTTYPE=image/jpeg:https://inflames.utu.fi/wp-content/uploads/2021/ 03/io-cancer.jpg END:VEVENT BEGIN:VEVENT UID:75@inflames.utu.fi DTSTART;TZID=Europe/Helsinki:20210413T150000 DTEND;TZID=Europe/Helsinki:20210413T160000 DTSTAMP:20230120T083147Z URL:https://inflames.utu.fi/events/cancer-research-seminar-virtual-event-2 / SUMMARY:Cancer Research Seminar - Virtual event DESCRIPTION:\n\nCancer Research Seminar Series – organized by Turku Cance r Research Society and FICAN West\n\nKarolina Louvanto \nMethylation marke rs in cervical cancer screening\n\nAkira Takeda \nStromal and immune cell interactions in health and disease\n\nZoom details:\nhttps://utu.zoom.us/j /67279196618\nMeeting ID: 672 7919 6618\nPasscode: 878028\n\n END:VEVENT BEGIN:VEVENT UID:72@inflames.utu.fi DTSTART;TZID=Europe/Helsinki:20210413T150000 DTEND;TZID=Europe/Helsinki:20210413T160000 DTSTAMP:20230120T083147Z URL:https://inflames.utu.fi/events/cancer-research-seminar-virtual-event/ SUMMARY:Cancer Research Seminar - Virtual event DESCRIPTION:\n\nCancer Research Seminar Series – organized by Turku Cance r Research Society and FICAN West\n\nKarolina Louvanto \nMethylation marke rs in cervical cancer screening\n\nAkira Takeda \nStromal and immune cell interactions in health and disease\n\nZoom details:\nhttps://utu.zoom.us/j /67279196618\nMeeting ID: 672 7919 6618\nPasscode: 878028\n\n END:VEVENT BEGIN:VEVENT UID:78@inflames.utu.fi DTSTART;TZID=Europe/Helsinki:20210420T140000 DTEND;TZID=Europe/Helsinki:20210420T160000 DTSTAMP:20230120T083147Z URL:https://inflames.utu.fi/events/immunology-seminar-series/ SUMMARY:Immunology Seminar Series | COVID-19 vaccination update and Tampere Vaccination Centre | InFLAMES flagship DESCRIPTION:Immunology seminar series is jointly organised by the Finnish S ociety for Immunology\, InFLAMES Flagship and Turku Bioscience\n\n Profes sor Mika Rämet: University of Tampere\n\nCOVID-19 vaccination update and Tampere Vaccination Centre\n\n Professor Sirpa Jalkanen: University of Tu rku\n\nInFLAMES flagship\nRegistration closes April 19th at 12:00.\nRegist er at: https://link.webropolsurveys.com/S/F283B4AB31C0B085\n\n \;\n\nZ oom link and iCalendar invitation to join the online event will be sent to all registered participants one day before the event. For further informa tion contact: Anne Lahdenperä (ankahy@utu.fi) or Riitta Lahesmaa (rilahes @utu.fi) END:VEVENT BEGIN:VEVENT UID:84@inflames.utu.fi DTSTART;TZID=Europe/Helsinki:20210422T110000 DTEND;TZID=Europe/Helsinki:20210422T114500 DTSTAMP:20230120T083147Z URL:https://inflames.utu.fi/events/turku-bioscience-postdoc-and-phd-semina r/ SUMMARY:Turku Bioscience Postdoc and PhD seminar DESCRIPTION:Professor Stefan Hell\, Max Planck Institute for Biophysical Ch emistry\nFlyer pdf\n\nProfessor Stefan Hell is a Nobel Laureate and an alu mnus of the University of Turku. Professor Stefan Hell will talk about his scientific journey and also interact with attendees.\n\nThe seminar is fo r forty-five minutes. It will be divided into two parts\, the first thirty minutes\, there will be a presentation by Prof. Stefan Hell\, and the las t fifteen minutes are assigned for discussion. Only a limited number of pa rticipants are allowed for the last fifteen minutes part so register quick ly!\n\nRegister latest April 21st at 17:00: https://link.webropolsurveys.c om/S/DBCD168098D78331\n\nProfessor Stefan Hell is a director at both the M ax Planck Institute for Biophysical Chemistry in Göttingen and the Max Pl anck Institute for Medical Research in Heidelberg\, Germany.\n\nStefan Hel l received his doctorate (1990) in physics from the University of Heidelbe rg. From 1991 to 1993 he worked at the European Molecular Biology Laborato ry\, followed by stays as a researcher at the University of Turku between 1993 and 1996. In 1997 he was appointed to the MPI for Biophysical Chemist ry in Göttingen as a group leader\, and was promoted to director in 2002. From 2003 to 2017 he also led a research group at the German Cancer Resea rch Center (DKFZ). Hell holds honorary professorships in physics at the Un iversities of Heidelberg and Göttingen.\n\nHe is credited with having con ceived\, validated and applied the first viable concept for overcoming Abb e’s diffraction-limited resolution barrier in a light-focusing fluoresce nce microscope. For this accomplishment he has received numerous awards\, including the 2014 Nobel Prize in Chemistry.\n\nSeminar is organized by Tu rku Bioscience Postdoc &\; Doctoral candidate board\nFor more informati on kindly contact Dr. Meraj Khan (mehakh@utu.fi) END:VEVENT BEGIN:VEVENT UID:24@inflames.utu.fi DTSTART;TZID=Europe/Helsinki:20210422T120000 DTEND;TZID=Europe/Helsinki:20210422T130000 DTSTAMP:20230120T083147Z URL:https://inflames.utu.fi/events/frontiers-of-science-climate-air-qualit y-and-covid/ SUMMARY:Frontiers of Science: Climate\, air quality and COVID DESCRIPTION: ATTACH;FMTTYPE=image/jpeg:https://inflames.utu.fi/wp-content/uploads/2021/ 02/kulmala-logot-2.jpg END:VEVENT BEGIN:VEVENT UID:81@inflames.utu.fi DTSTART;TZID=Europe/Helsinki:20210429T090000 DTEND;TZID=Europe/Helsinki:20210429T120000 DTSTAMP:20230120T083147Z URL:https://inflames.utu.fi/events/day-of-immunology-iuis-efis-webinar-imm unology-in-the-time-of-covid-19-achievements-challenges-and-opportunities/ SUMMARY:Day of Immunology - IUIS-EFIS Webinar. Immunology in the time of CO VID-19: achievements\, challenges and opportunities DESCRIPTION:Join IUIS President Faith Osier and EFIS President Andreas Radb ruch in celebrating the Day of Immunology 2021 as they host this live webi nar on April 29 (3-6 p.m. CET).\n\nFeaturing talks by Özlem Türeci\, Dav ide Corti\, Shane Crotty\, Laurence Zitvogel\, and a special opening messa ge from Anthony Fauci\, a panel discussion among internationally acclaim ed experts in immunology\, virology\, vaccinology and public health\, mode rated by editors from European Journal of Immunology\, Nature Medicine\, S cience and Bhekisisa\, will round off the event.\n\nFull schedule of the e vent END:VEVENT BEGIN:VEVENT UID:30@inflames.utu.fi DTSTART;TZID=Europe/Helsinki:20210429T180000 DTEND;TZID=Europe/Helsinki:20210429T190000 DTSTAMP:20230120T083147Z URL:https://inflames.utu.fi/events/frontiers-of-science-cell-atlases-as-ro admaps-to-treat-disease/ SUMMARY:CANCELLED: Frontiers of Science: Cell Atlases as roadmaps to treat disease DESCRIPTION: ATTACH;FMTTYPE=image/jpeg:https://inflames.utu.fi/wp-content/uploads/2021/ 02/regev_logot.jpg END:VEVENT BEGIN:VEVENT UID:87@inflames.utu.fi DTSTART;TZID=Europe/Helsinki:20210503T030000 DTEND;TZID=Europe/Helsinki:20210503T050000 DTSTAMP:20230120T083147Z URL:https://inflames.utu.fi/events/societal-and-economic-impacts-and-value -of-advanced-treatments-for-inflammatory-diseases-docent-juha-laine/ SUMMARY:Professor of Practice Lecture - Juha Laine DESCRIPTION:Juha Laine’s lecture Societal and economic impacts and value of advanced treatments for inflammatory diseases is held on 3 May at 3PM. After Laine’s lecture\, Professor Mika Kortelainen will give a lecture C ovid-19 Pandemic in Finland: Real-time health economic evaluation. Follow the webinar from here.\n\nDocent Juha Laine has been appointed as Professo r of Practice in Pharmacoeconomics. The appointment strengthen the operati ons of the InFLAMES Flagship\, joint effort of the University of Turku and Åbo Akademi University\, funded by the Academy of Finland. The purpose b ehind the professorship of practice in pharmacoeconomics is to increase th e societal impact of research and collaboration between the University and pharmaceutical companies.\n\nThe newly-appointed Professor of Practice in Pharmacoeconomics Juha Laine has a PhD in Health Economics and is Docent of Pharmacoeconomics and Health Economics. Laine works in the pharmaceutic al company Roche. In his job\, he is responsible for coordinating research that uses real world data such as register-based research while also work ing as a health economics advisor. The University of Turku has had a colla boration agreement with Roche since 2018. Laine’s recruitment as a profe ssor of practise is an additional step in the co-operation of Roche and th e University of Turku.\n\n\n\nProfessor of Practice Juha Laine will give a lecture in open webinar organised on 3 May 2021 at 3 PM. Juha Laine’s l ecture title is Societal and economic impacts and value of advanced treatm ents for inflammatory diseases. After Laines lecture\, Professor Mika Kort elainen will give a lecture Covid-19 Pandemic in Finland: Real-time health economic evaluation.\n\n\n\n\n\nAdditional information\nJuha Laines Profe ssor of Practice Lecture - Open Webinar\n\nKaisa Hakkila\nkaisa.hakkila@ut u.fi\n\n\n END:VEVENT BEGIN:VEVENT UID:27@inflames.utu.fi DTSTART;TZID=Europe/Helsinki:20210506T120000 DTEND;TZID=Europe/Helsinki:20210506T130000 DTSTAMP:20230120T083219Z URL:https://inflames.utu.fi/events/frontiers-of-science-mechanobiology-of- intestinal-organoids/ SUMMARY:Frontiers of Science: Mechanobiology of intestinal organoids DESCRIPTION: ATTACH;FMTTYPE=image/jpeg:https://inflames.utu.fi/wp-content/uploads/2021/ 02/trepat_logot.jpg END:VEVENT BEGIN:VEVENT UID:90@inflames.utu.fi DTSTART;TZID=Europe/Helsinki:20210517T150000 DTEND;TZID=Europe/Helsinki:20210517T163000 DTSTAMP:20230120T083219Z URL:https://inflames.utu.fi/events/professor-of-practice-lecture-timo-vero maa/ SUMMARY:Professor of Practice Lecture - Timo Veromaa DESCRIPTION:\n\n\nDr. Timo Veromaa has been appointed as Professor of Pract ice in Drug Development. The appointment strengthen the operations of the InFLAMES Flagship\, joint effort of the University of Turku and Åbo Akade mi University\, funded by the Academy of Finland. The purpose of the profe ssorship of practice in drug development is to introduce more life science business and innovation expertise to the University of Turku\, increase c ollaboration between the University and pharmaceutical companies\, and hel p enable commercialisation of innovations.\n\nTimo Veromaa is an MD\, PhD with a research background and an eMBA from the University of Turku. He ha s worked in utive and board level positions in life science and health tec hnology companies in Finland\, United States\, Great Britain\, Germany\, S weden\, and Switzerland for over 25 years. As the CEO of the drug developm ent company Biotie Therapies Plc.\, listed on the stock exchange in Finlan d and the U.S.\, Veromaa was responsible for shareholder and investor rela tions and for national and international public and private funding agenci es.\n\nVeromaa is currently Chairman of the Board of Herantis Pharma Plc\, drug development company working on gene therapy and biologics listed on the First North Growth Market stock exchange both in Helsinki and Stockhol m\, as well as first Chairman of Finnish Biobanks FINBB. Veromaa has had a n active role in various public sector projects of the field\, developing the prerequisites for business activities in Finland and has worked in var ious positions of trust.\n\nProfessor of Practice Timo Veromaa will give a lecture in open webinar organised on 17 May 2021 at 3 PM. Timo Veromaa’ s lecture title is Building a globally competitive precision medicine ecos ystem in Turku\, Finland.\n\n\n\n\n\nAdditional information\nTimo Veromaas Professor of Practice Lecture - Open Webinar\n\n\nKaisa Hakkila\nkaisa.ha kkila@utu.fi\n\n END:VEVENT BEGIN:VEVENT UID:54@inflames.utu.fi DTSTART;TZID=Europe/Helsinki:20210518T140000 DTEND;TZID=Europe/Helsinki:20210518T150000 DTSTAMP:20230120T083219Z URL:https://inflames.utu.fi/events/role-of-complement-in-pregnancy-disorde rs/ SUMMARY:Role of complement in pregnancy disorders DESCRIPTION:Seppo Meri\, University of Helsinki: Role of complement in preg nancy disorders\n\nRegister latest May 17th at: https://link.webropolsurve ys.com/S/0B9738AEBC03A3C1 END:VEVENT BEGIN:VEVENT UID:93@inflames.utu.fi DTSTART;TZID=Europe/Helsinki:20210621T130000 DTEND;TZID=Europe/Helsinki:20210621T130000 DTSTAMP:20230120T083220Z URL:https://inflames.utu.fi/events/turku-bioscience-post-doc-and-phd-semin ar-professor-adrian-liston/ SUMMARY:Turku Bioscience Post Doc and PhD seminar: Professor Adrian Liston DESCRIPTION:Virtual event\n\nSpeaker: Professor Adrian Liston\n\nTime: 21st June 13:00\n\nTentative Title: A cynic’s guide to getting a faculty pos ition… and succeeding in it!\n\nThe seminar is for forty-five minutes. I t will be divided into two parts. For the first thirty minutes\, there wil l be a presentation by Prof. Adrian Liston\,followed by 15 minutes discuss ion.\n\nPlease register via this link:  https://link.webropol.com/s/phdpo stdocseminarseries\n\nRegistration closes 20th June at 23:59.\nAbout the s peaker\nProf Adrian Liston\, is a Senior Group Leader at the Babraham Inst itute and Senior Research Fellow at Churchill College\, University of Camb ridge.\n\nListon got his PhD at the Australian National University\, follo wed by post-doctoral research on regulatory T cell biology with Professor Sasha Rudensky at the University of Washington.\n\nFrom 2009-2018\, Prof L iston ran his independent laboratory at the VIB and the University of Leuv en\, in Belgium. In 2019\, Liston relocated his research team to the Babra ham Institute\, in Cambridge\, UK.\n\nProfessor Liston has been recently e lected a Fellow of the prestigious Academy of Medical Sciences for his pio neering research in immunology and neuroimmunology. Fellows of the Academy of Medical Sciences are elected for exceptional contributions to the medi cal sciences either in the form of original discovery or of sustained cont ributions to scholarship. Professor Liston has also been awarded the Franc qui Chair\, the Eppendorf Prize\, a Wellcome Trust Investigator Award and three ERC grants\, among other honours. The Liston laboratory currently wo rks on understanding the interaction between the immune system and the tis sues\, in particular the brain. The laboratory has extensive experience in the fields of autoimmune genetics\, diabetes\, primary immunodeficiencies \, the thymus and regulatory T cells and has published more than 180 scien tific papers\, in the respective fields.\n\nMore details about this resear ch can be found here http://www.liston.babraham.ac.uk/liston/\n\nSeminar i s organized by Turku Bioscience Postdoc &\; Doctoral candidate board\n\ nFor more information kindly contact Bilal Andrabi (sbaand@utu.fi) END:VEVENT BEGIN:VEVENT UID:69@inflames.utu.fi DTSTART;TZID=Europe/Helsinki;VALUE=DATE:20210819 DTEND;TZID=Europe/Helsinki;VALUE=DATE:20210821 DTSTAMP:20230120T083220Z URL:https://inflames.utu.fi/events/30th-biocity-symposium-14th-finnish-can cer-institute-symposium/ SUMMARY:30th BioCity Symposium / 14th Finnish Cancer Institute Symposium DESCRIPTION: ATTACH;FMTTYPE=image/jpeg:https://inflames.utu.fi/wp-content/uploads/2021/ 03/400px-neilo.jpg END:VEVENT BEGIN:VEVENT UID:57@inflames.utu.fi DTSTART;TZID=Europe/Helsinki:20210921T140000 DTEND;TZID=Europe/Helsinki:20210921T160000 DTSTAMP:20230120T083220Z URL:https://inflames.utu.fi/events/tba/ SUMMARY:Immunology seminar: Satu Mustjoki DESCRIPTION:Sebtember 21st at 14:00\nVirtual event\n\nSatu Mustjoki\, Unive rsity of Helsinki: Somatic mutations in (non-malignant) immune-mediated di seases.\n\nRegister latest September 20th at: https://link.webropolsurveys .com/S/525C915E3FD18EF0\n\n \;\n\n \; END:VEVENT BEGIN:VEVENT UID:96@inflames.utu.fi DTSTART;TZID=Europe/Helsinki:20210923T170000 DTEND;TZID=Europe/Helsinki:20210923T180000 DTSTAMP:20230120T083220Z URL:https://inflames.utu.fi/events/frontiers-of-science-alberto-j-espay/ SUMMARY:Frontiers of Science: Alberto J. Espay DESCRIPTION: ATTACH;FMTTYPE=image/jpeg:https://inflames.utu.fi/wp-content/uploads/2021/ 08/Espay_Fos.jpg END:VEVENT BEGIN:VEVENT UID:99@inflames.utu.fi DTSTART;TZID=Europe/Helsinki:20211007T150000 DTEND;TZID=Europe/Helsinki:20211007T160000 DTSTAMP:20230120T083220Z URL:https://inflames.utu.fi/events/frontiers-of-science-teng-leong-chew/ SUMMARY:Frontiers of Science: Teng-Leong Chew DESCRIPTION: ATTACH;FMTTYPE=image/jpeg:https://inflames.utu.fi/wp-content/uploads/2021/ 08/Chew_Fos_400.jpg END:VEVENT BEGIN:VEVENT UID:117@inflames.utu.fi DTSTART;TZID=Europe/Helsinki:20211011T110000 DTEND;TZID=Europe/Helsinki:20211011T120000 DTSTAMP:20230120T083220Z URL:https://inflames.utu.fi/events/introductory-lecture-simon-goodman/ SUMMARY:Introductory lecture: Simon Goodman DESCRIPTION:Date/Time\nDate(s) - 11/10/2021\n11:00 am - 12:00 pm\n\nOctober 11th at 11:00\n\nProfessor Simon Goodman\, Science and Technology Program Manager\, the Antibody Society\, Germany\n\nIntroductory lecture: Drug di scovery and how things are done in pharma\n\n.\n\nRegister latest Sunday O ctober 10th  \n\nhttps://link.webropol.com/s/VP-Simon-Goodman\n\n.\n\nPro fessor Goodman will be holding his introductory lecture in the Medisiina D Lecture Hall Lauren 1 on Monday October 11th  at 11:15. We welcome eve rybody to come and listen! The lecture can also be attended via zoom conne ction (no registration required):\n\nhttps://utu.zoom.us/j/66366373791\n\n .\n\nSimon L. Goodman\n\nSimon is Science and Technology Program Manager f or the Antibody Society. He gained his D.Phil in membrane biochemistry fro m the University of Sussex. His start-up biotechnology company works on an tibody validation.  He spent many years at Merck inventing and developing peptide and antibody therapeutics targeting cell adhesion through phase 3 clinical trials in oncology. Prior to Merck\, he did post-doctoral work a t Max-Planck Society on cellular receptors for laminin\, with Klaus von de r Mark at Martinsried\, Munich and Erlangen\, and phenotypic antibody scre ens with Walter Birchmeier at MPI Tübingen. His work includes the first h igh resolution X-ray structures of integrins\, in collaboration with Dr. A min Arnaout (Harvard Medical School).  His career in academia and industr y has resulted in over 100 peer-reviewed publications\, reviews and in man y patents. ATTACH;FMTTYPE=image/jpeg:https://inflames.utu.fi/wp-content/uploads/2021/ 10/Pik-Simon-square.jpg END:VEVENT BEGIN:VEVENT UID:120@inflames.utu.fi DTSTART;TZID=Europe/Helsinki:20211012T150000 DTEND;TZID=Europe/Helsinki:20211012T160000 DTSTAMP:20230120T083220Z URL:https://inflames.utu.fi/events/visiting-professor-lecture-simon-goodma n/ SUMMARY:Visiting professor lecture: Simon Goodman DESCRIPTION:Date/Time\nDate(s) - 12/10/2021\n15:00 am - 16:00 pm\n\nOctober 12th at 15:00\n\nProfessor Simon Goodman\, Science and Technology Program Manager\, the Antibody Society\, Germany\n\nIntegrins as drug targets\n\n .\n\nRegister latest Sunday October 10th  \n\nhttps://link.webropol.com/s /VP-Simon-Goodman\n\n.\n\nProfessor Goodman will be holding his a lecture about the topic of Integrins as drug targets in the Medisiina D Lecture Ha ll Lauren 1 on Tuesday October 12th  at 15:15. We welcome everybody to co me and listen! The lecture can also be attended via zoom connection (no re gistration required):\n\nhttps://utu.zoom.us/j/61710469294\n\n.\n\nSimon L . Goodman\n\nSimon is Science and Technology Program Manager for the Antib ody Society. He gained his D.Phil in membrane biochemistry from the Univer sity of Sussex. His start-up biotechnology company works on antibody valid ation.  He spent many years at Merck inventing and developing peptide and antibody therapeutics targeting cell adhesion through phase 3 clinical tr ials in oncology. Prior to Merck\, he did post-doctoral work at Max-Planck Society on cellular receptors for laminin\, with Klaus von der Mark at Ma rtinsried\, Munich and Erlangen\, and phenotypic antibody screens with Wal ter Birchmeier at MPI Tübingen. His work includes the first high resoluti on X-ray structures of integrins\, in collaboration with Dr. Amin Arnaout (Harvard Medical School).  His career in academia and industry has result ed in over 100 peer-reviewed publications\, reviews and in many patents. ATTACH;FMTTYPE=image/jpeg:https://inflames.utu.fi/wp-content/uploads/2021/ 10/Pik-Simon-square.jpg END:VEVENT BEGIN:VEVENT UID:126@inflames.utu.fi DTSTART;TZID=Europe/Helsinki:20211019T140000 DTEND;TZID=Europe/Helsinki:20211019T150000 DTSTAMP:20230120T083220Z URL:https://inflames.utu.fi/events/immunology-seminar-ilkka-junttila/ SUMMARY:Immunology Seminar - Ilkka Junttila DESCRIPTION:October 19th  2021 at 14.00-15.00\n\nVirtual event\n\n \;\ n\nIlkka Junttila\, Tampere University\nCytokine Landscape of Allergic Inf lammation \n\nHost: Riitta Lahesmaa (rilahes@utu.fi)\n\n \;\n\nRegiste r latest October 18th\nhttps://link.webropolsurveys.com/S/8BE883FC8E5AED43 \n\nZoom link and iCalendar invitation to join the online event will be se nt to all registered participants one day before the event.\n\nImmunology seminar series is jointly organised by the Finnish Society for Immunology\ , InFLAMES Flagship and Turku Bioscience. For further information contact Anne Lahdenperä (ankahy@utu.fi) or Riitta Lahesmaa (rilahes@utu.fi)\, Uni versity of Turku.\n\n***************\n\nDr. Ilkka Junttila\, MD\, PhD is c urrently Academy of Finland Research Fellow at Tampere University. He has received his MD (2001)\, PhD (2005) and Specialist Degree in Medicine (Cli nical microbiology\, 2014) all at the University of Tampere. He also recei ved the title of docent (Clinical microbiology\, 2017) at the University o f Tampere.\n\nHe did his post-doctoral training with Bill Paul at the Labo ratory of Immunology at the National Institute of Allergy and Infectious D iseases\, National Institutes of Health between 2006 and 2011. Since then\ , he has focused with his team on pathophysiological mechanisms of allergi c inflammation and in particular the effect of allergy-related cytokines o n myeloid cells. He is especially interested on cytokines that share funct ional receptors (IL-4/IL-13 and IL-7/TSLP) and the logics of such receptor sharing in the immune system. Quite recently he has also become intereste d in the interactions of immune system\, inflammation and malignant cell g rowth.\n\nCurrently he leads the Cytokine Biology Research group at Tamper e University. His research is mainly funded mainly by the Academy of Finla nd and Tampere Tuberculosis Foundation. In 2014\, he also received Finnish Medical Foundation 175 000 Eur funding for his research. He has publishe d approximately 30 scientific publications and his lead-author publication s include Journal of Experimental Medicine\, Nature Chemical Biology and J ournal of Allergy and Clinical Immunology.\n\nSelected publications:\n1. J unttila IS. Tuning the Cytokine Responses: An Update on Interleukin (IL)-4 and IL-13 Receptor Complexes. Front Immunol. 2018. 9:888.\n\n2. Kummola L \, Ortutay Z\, Chen X\, Caucheteux S\, Hämäläinen S\, Aittomäki S\, Ya gi R\, Zhu J\, Pesu M\, Paul WE\, Junttila IS. IL-7Rα Expression Regulate s Murine Dendritic Cell Sensitivity to Thymic Stromal Lymphopoietin. J Imm unol. 2017. 198:3909-3918.\n\n3. Junttila IS\, Watson C\, Kummola L\, Chen X\, Hu-Li J\, Guo L\, Yagi R\, Paul WE. Efficient cytokine-induced IL-13 production by mast cells requires both IL-33 and IL-3. J Allergy Clin Immu nol. 2013. 132:704-712.\n\n4. Junttila IS\, Creusot RJ\, Moraga I\, Bates DL\, Wong MT\, Alonso MN\, Suhoski MM\, Lupardus P\, Meier-Schellersheim M \, Engleman EG\, Utz PJ\, Fathman CG\, Paul WE\, Garcia KC.Redirecting cel l-type specific cytokine responses with engineered interleukin-4 superkine s. Nat Chem Biol. 2012. 8:990-998.\n\n5. Junttila IS\, Mizukami K\, Dicken sheets H\, Meier-Schellersheim M\, Yamane H\, Donnelly RP\, Paul WE. Tunin g sensitivity to IL-4 and IL-13: differential expression of IL-4Ralpha\, I L-13Ralpha1\, and gammac regulates relative cytokine sensitivity. J Exp Me d. 2008. 205:2595-2608. ATTACH;FMTTYPE=image/jpeg:https://inflames.utu.fi/wp-content/uploads/2021/ 10/Immunology-seminar-October-19.png END:VEVENT BEGIN:VEVENT UID:102@inflames.utu.fi DTSTART;TZID=Europe/Helsinki:20211021T180000 DTEND;TZID=Europe/Helsinki:20211021T190000 DTSTAMP:20230120T083220Z URL:https://inflames.utu.fi/events/frontiers-of-science-aviv-regev/ SUMMARY:Frontiers of Science: Aviv Regev DESCRIPTION: ATTACH;FMTTYPE=image/jpeg:https://inflames.utu.fi/wp-content/uploads/2021/ 08/Regev_fos_400.jpg END:VEVENT BEGIN:VEVENT UID:123@inflames.utu.fi DTSTART;TZID=Europe/Helsinki:20211102T120000 DTEND;TZID=Europe/Helsinki:20211102T130000 DTSTAMP:20230120T083220Z URL:https://inflames.utu.fi/events/biocity-guest-seminar-hannu-larjava/ SUMMARY:BioCity Guest Seminar: Hannu Larjava DESCRIPTION:November 2nd  2021 at 12.00\n\nPresident Auditorium\, Mauno C onference Centre\, BioCity\n\n \;\n\nProfessor Hannu Larjava\, Univers ity of British Columbia\, Vancouver\, Canada\n\nRegulation of Periodontal Inflammation by alphaVbeta6 Integrin: From Bench to Clinic\n\nHost: Jyrki Heino (jyheino@utu.fi)\n\n.\n\n \; END:VEVENT BEGIN:VEVENT UID:105@inflames.utu.fi DTSTART;TZID=Europe/Helsinki:20211104T120000 DTEND;TZID=Europe/Helsinki:20211104T130000 DTSTAMP:20230120T083220Z URL:https://inflames.utu.fi/events/frontiers-of-science-jacco-van-rheenen/ SUMMARY:Frontiers of Science: Jacco van Rheenen DESCRIPTION: ATTACH;FMTTYPE=image/jpeg:https://inflames.utu.fi/wp-content/uploads/2021/ 08/vanRheenen_fos_400.jpg END:VEVENT BEGIN:VEVENT UID:129@inflames.utu.fi DTSTART;TZID=Europe/Helsinki:20211108T110000 DTEND;TZID=Europe/Helsinki:20211108T120000 DTSTAMP:20230120T083220Z URL:https://inflames.utu.fi/events/inflames-visiting-professor-lecture-sar ah-coupland-an-update-on-ocular-melanoma/ SUMMARY:InFLAMES Visiting Professor Introductory Lecture\, Sarah Coupland: My journey as a female clinical academic histopathologist: building sandca stles and dodging landmines DESCRIPTION:Date/Time\nDate(s) - 08/11/2021\n11:00 am - 12:a0 noon\n\n<\; style="clear:both">\;\n\nNovember 8th  2021 at 11.00\n\nMED D1016 Laure n-sali 2\, Medisiina D\, Kiinamyllynkatu 10 20520 Turku\n\nhttps://utu.zoo m.us/j/65183079833\n\n \;\n\nProfessor Sarah Coupland\, University of Liverpool\, UK\n\nIntroductory Lecture: My journey as a female clinical ac ademic histopathologist: building sandcastles and dodging landmines\n\nHos t: Sampo Koivunen (sampo.koivunen@utu.fi)\n\n<\;/style="clear:both">\; END:VEVENT BEGIN:VEVENT UID:132@inflames.utu.fi DTSTART;TZID=Europe/Helsinki:20211109T153000 DTEND;TZID=Europe/Helsinki:20211109T163000 DTSTAMP:20230120T083220Z URL:https://inflames.utu.fi/events/inflames-visiting-professor-lecture-sar ah-coupland-an-update-on-ocular-melanoma-2/ SUMMARY:InFLAMES Visiting Professor Lecture\, Sarah Coupland: An update on Ocular melanoma DESCRIPTION:Date/Time\nDate(s) - 09/11/2021\n15:30 am - 16:30 noon\n\n<\; style="clear:both">\;\n\nNovember 9th  2021 at 15.30\n\nMED D1016 Laure n-sali 2\, Medisiina D\, Kiinamyllynkatu 10 20520 Turku\n\nhttps://utu.zoo m.us/j/68259129510\n\n \;\n\nProfessor Sarah Coupland\, University of Liverpool\, UK\n\nAn update on Ocular melanoma\n\nHost: Sampo Koivunen (sa mpo.koivunen@utu.fi)\n\n<\;/style="clear:both">\; END:VEVENT BEGIN:VEVENT UID:108@inflames.utu.fi DTSTART;TZID=Europe/Helsinki:20211118T120000 DTEND;TZID=Europe/Helsinki:20211118T130000 DTSTAMP:20230120T083220Z URL:https://inflames.utu.fi/events/frontiers-of-science-janne-lehtio/ SUMMARY:Frontiers of Science: Janne Lehtiö DESCRIPTION: ATTACH;FMTTYPE=image/jpeg:https://inflames.utu.fi/wp-content/uploads/2021/ 08/Lehtio_fos_400.jpg END:VEVENT BEGIN:VEVENT UID:60@inflames.utu.fi DTSTART;TZID=Europe/Helsinki:20211123T140000 DTEND;TZID=Europe/Helsinki:20211123T150000 DTSTAMP:20230120T083220Z URL:https://inflames.utu.fi/events/type-1-diabetes-prediction-and-preventi on-dipp-study-what-have-we-learned/ SUMMARY:Immunology Seminar Series | Type 1 Diabetes Prediction and Preventi on (DIPP) Study - what have we learned? DESCRIPTION:Virtual event\n\nRiitta Veijola\, University of Oulu and Oulu U niversity Hospital\nType 1 Diabetes Prediction and Prevention (DIPP)\n\nHo st: Riitta Lahesmaa (rilahes@utu.fi)\n\nRegister latest November 22nd at:\ nhttps://link.webropolsurveys.com/S/1810BF8DB7BFF08D\n\nZoom link and iCal endar invitation to join the online event will be sent to all registered p articipants one day before the event.\n\nImmunology seminar series is join tly organised by the Finnish Society for Immunology\, InFLAMES Flagship an d Turku Bioscience. For further information contact Anne Lahdenperä (anka hy@utu.fi) or Riitta Lahesmaa (rilahes@utu.fi)\, University of Turku.\n\n. \n\nDr. Riitta Veijola is Professor of  Pediatrics at the University of O ulu and Oulu University Hospital.  She has basic clinical training in ped iatrics and pediatric endocrinology and has a strong track record in type 1 diabetes research. She received her medical degree (1985) and PhD degree (1996) at the University of Oulu\, after which she did her specialty degr ee in Pediatric Endocrinology.\n\nSince 2001\, Riitta Veijola has been res ponsible for the Finnish Type 1 Diabetes Prediction and Prevention (DIPP) Study\, which is an ongoing large prospective study at three university ho spitals (Turku\, Oulu and Tampere)  in Finland since 1994. The DIPP study currently has appr. 6000 children aged 0-15 years in Finland. Together wi th the researchers in the DIPP Study Riitta Veijola has published more tha n 200 papers on genetics\, prediction and pathogenesis of type 1 diabetes. \n\nSelected publications:\n\n Anand V\, Li Y\, Liu B\, Ghalwash M\, Kosk i E\, Ng K\, Dunne JL\, Jönsson J\, Winkler C\, Knip M\, Toppari J\, Ilon en J\, Killian MB\, Frohnert BI\, Lundgren M\, Ziegler AG\, Hagopian W\, V eijola R\, Rewers M\; T1DI Study Group. Islet Autoimmunity and HLA Markers of Presymptomatic and Clinical Type 1 Diabetes: Joint Analyses of Prospec tive Cohort Studies in Finland\, Germany\, Sweden\, and the U.S. Diabetes Care 2021 Jun 23:dc201836. doi: 10.2337/dc20-1836. Epub ahead of print. PM ID: 34162665.\n Ilonen J\, Lempainen J\, Veijola R. The heterogeneous pat hogenesis of type 1 diabetes mellitus. Nat Rev Endocrinol 2019\;15:635-650 . doi:10.1038/s41574-019-0254-y.\n Koskinen MK\, Lempainen J\, Löyttynie mi E\, Helminen O\, Hekkala A\, Härkönen T\, Kiviniemi M\, Simell O\, Kn ip M\, Ilonen J\, Toppari J\, Veijola R. Class II HLA Genotype Association with First Phase Insulin Response Is Explained by Islet Autoantibodies. J Clin Endocrinol Metab 2018 Aug 1\;103(8):2870-2878. doi: 10.1210/jc.2017- 02040.\n\n \; END:VEVENT BEGIN:VEVENT UID:135@inflames.utu.fi DTSTART;TZID=Europe/Helsinki:20211125T101500 DTEND;TZID=Europe/Helsinki:20211125T141500 DTSTAMP:20230120T083220Z URL:https://inflames.utu.fi/events/inflames-fcai-seminar-on-medical-imagin g/ SUMMARY:InFLAMES-FCAI Seminar on Medical Imaging DESCRIPTION:Finnish Center for Artificial Intelligence FCAI and Innovation Ecosystem based on the Immune System (InFLAMES) will organize an AIX Forum event on November 25\, 2021.\n\nPlace: Klondyke\, Dipoli\, Espoo + remote possibility via https://aalto.zoom.us/j/63016724408 \nTime: November 25\, 10:15–14:15\n\n10:15–10:30 InFLAMES and FCAI introductions\n10:30–1 1:00 Keynote 1 (20 min + 10 min) - Pasi Kankaanpää: Turku BioImaging - i maging coordination and image data services\n11:00–11:30 Keynote 2 (20 m in + 10 min) - Hanna Renvall & Lauri Parkkonen: AI in brain imaging: emerg ing applications\n11:30–12:30 Self-financed lunch\n12:30–13:00 Keynote 3 (20 min + 10 min) - Juhani Knuuti: Big data analysis in cardiovascular diseases\n13:00–13:30 Keynote 4 (20 min + 10 min) - Aleksei Tiulpin: Dia gnosing and forecasting degenerative disorders from multimodal data using deep learning\n13:30–14:00 Keynote 5 (20 min + 10 min) - John Eriksson: Euro-Bioimaging - Cutting-edge imaging linked to big data and AI\n14:00– 14:15 Wrap up and next steps END:VEVENT BEGIN:VEVENT UID:111@inflames.utu.fi DTSTART;TZID=Europe/Helsinki:20211202T120000 DTEND;TZID=Europe/Helsinki:20211202T130000 DTSTAMP:20230120T083220Z URL:https://inflames.utu.fi/events/frontiers-of-science-petter-brodin/ SUMMARY:Frontiers of Science: Petter Brodin DESCRIPTION: ATTACH;FMTTYPE=image/jpeg:https://inflames.utu.fi/wp-content/uploads/2021/ 08/Broadin_Fos_400.jpg END:VEVENT BEGIN:VEVENT UID:63@inflames.utu.fi DTSTART;TZID=Europe/Helsinki:20211207T140000 DTEND;TZID=Europe/Helsinki:20211207T150000 DTSTAMP:20230120T083246Z URL:https://inflames.utu.fi/events/t-cell-studies-in-type-1-diabetes/ SUMMARY:T cell studies in type 1 diabetes DESCRIPTION:Tuure Kinnunen\, University of Eastern Finland: T cell studies in type 1 diabetes\n\nRegister latest December 5th at: https://link.webrop olsurveys.com/S/111057C69B07821C\n\n \; END:VEVENT BEGIN:VEVENT UID:114@inflames.utu.fi DTSTART;TZID=Europe/Helsinki:20211216T120000 DTEND;TZID=Europe/Helsinki:20211216T130000 DTSTAMP:20230120T083246Z URL:https://inflames.utu.fi/events/frontiers-of-science-bert-degroot/ SUMMARY:Frontiers of Science: Bert deGroot DESCRIPTION: ATTACH;FMTTYPE=image/jpeg:https://inflames.utu.fi/wp-content/uploads/2021/ 08/deGroot_Fos_400.jpg END:VEVENT BEGIN:VEVENT UID:136@inflames.utu.fi DTSTART;TZID=Europe/Helsinki:20211216T140000 DTEND;TZID=Europe/Helsinki:20211216T170000 DTSTAMP:20240416T113653Z URL:https://inflames.utu.fi/events/inflames-flagship-corporate-corner/ SUMMARY:InFLAMES Flagship Corporate Corner DESCRIPTION:InFLAMES Flagship welcomes our existing and new collaborative p artners to our first Corporate Corner. The event will be the first of the upcoming Corporate Corner series\, which continues next year in March 2022 .  You are welcome to send us suggestions on the content of future events .\n\nThe event will be held on the 16th of December\, 2021 at 2:00-5.00 pm in the President Auditorium of the Conference Center Mauno in BioCity\, T urku. Due to the COVID-19 situation in Finland\, participation is also po ssible online.\n\nIn accordance with the instructions of the Occupational Safety and Health Administration in Finland\, the COVID-19 passport is re quired from participants attending the event on site.\n\n \;\n\nYou ar e also welcome to join us online and participate in the discussion!\n\nZoo m-link: https://us02web.zoom.us/j/85377051465?pwd=WW9pSVptUHFlUVowRkk3MW9w SDJsZz09\n\n \;\n\nPROGRAMME\n\n\n\n\n13:45-14:00\nCoffee and tea\n\n\ n14:00-14:30\n\n \;\n\n \;\nInFLAMES Research Flagship\nWho are we ? What can we offer to industrial partners?\nCome and learn with us!\nInFL AMES Director Sirpa Jalkanen\n\n\n\n14:30-16:00\n\n \;\n\n \;\n\n& nbsp\;\n\n \;\n\n \;\n\n \;\n\n \;\n\n \;\n\n \;\n \n \;\n\n \;\n\n \;\nHighlights of Our Research\n\nRegulation of human immune response\nProfessor Riitta Lahesmaa\, Turku Bioscience Cen tre\n\nLeukocyte trafficking in inflammation: crossing borders\nProfessor Marko Salmi\, Institute of Biomedicine\n\nNext generation immunotherapies -Making cancer weapons out of macrophages\nAcademy Research Fellow Maija H ollmen\, Institute of Biomedicine\n\nTurning hot microglia cold to stop ne urodegeneration\nProfessor Laura Airas\, Turku PET Centre\n\nClosing words \nProfessor of Practice Timo Veromaa\, InFLAMES Flagship\n\n \;\n\n\n1 6:00-17:00\nNetworking\nNetworking session with good wine and food.\n\n\n\ n\nKaisa Hakkila\n\nProject Manager\n\nInFLAMES Research Flagship\n\nkaisa .hakkila@utu.fi | +358 50 526 7057 CATEGORIES:Corporate Corner END:VEVENT BEGIN:VEVENT UID:145@inflames.utu.fi DTSTART;TZID=Europe/Helsinki:20220201T140000 DTEND;TZID=Europe/Helsinki:20220201T150000 DTSTAMP:20230120T083246Z URL:https://inflames.utu.fi/events/immunology-seminar-jenny-mjosberg/ SUMMARY:Immunology Seminar\, Jenny Mjösberg DESCRIPTION: ATTACH;FMTTYPE=image/jpeg:https://inflames.utu.fi/wp-content/uploads/2022/ 01/Jenny-mjosberg_final.jpg END:VEVENT BEGIN:VEVENT UID:147@inflames.utu.fi DTSTART;TZID=Europe/Helsinki:20220201T140000 DTEND;TZID=Europe/Helsinki:20220201T150000 DTSTAMP:20230120T083246Z URL:https://inflames.utu.fi/events/immunology-seminar-jenny-mjosberg-2/ SUMMARY:Immunology Seminar\, Jenny Mjösberg DESCRIPTION:Immunology Seminar\n\nFebruary 1st at 14:00 – 15:00\nVirtual event\n\nJenny Mjösberg\, Karolinska Institute\nTissue- and Inflammation- Specific Imprinting of Human Innate Lymphoid Cells\n\nHost: Riitta Lahesma a (rilahes@utu.fi) END:VEVENT BEGIN:VEVENT UID:146@inflames.utu.fi DTSTART;TZID=Europe/Helsinki:20220203T110000 DTEND;TZID=Europe/Helsinki:20220203T120000 DTSTAMP:20230120T083246Z URL:https://inflames.utu.fi/events/inflames-visitor-associate-professor-ma ria-yuseff-guest-seminar/ SUMMARY:InFLAMES Visitor Guest Seminar: Associate Professor María Yuseff DESCRIPTION:A Special seminar by the EMBO Global Investigator\, Associate P rof María Isabel Yuseff\, the Pontificia Universidad Catolica de Chile\, on next Tuesday 1.2. at 13:00 in Lauren-2 lecture hall.\n\n \;\n\nThe title of her talk is:\n\nCoupling Cytoskeleton Dynamics to Polarized lysos ome Trafficking: Impact on B cell Responses.\n\n \;\n\nDr Yuseff’s r esearch in immune cell biology focuses on addressing two fundamental quest ions: 1. How B lymphocytes orchestrate cytoskeleton and organelle dynamics (lysosome/ER) to promote their antigen processing and presenting function s\, and 2. How are these processes are tuned in inflammation responses and in pathologies such as autoimmunity. By combining cell biological approac hes and immunological assays the research group recently revealed two mech anisms that regulate membrane trafficking at the B cell synapse\, enabling them to become competent as antigen presenting cells. The first one invol ves the exocyst complex\, which is assembled upon B cell activation and re gulates local exocytosis of lysosomes at the synaptic membrane. The second one involves local protein degradation\, controlled by the proteasome\, w hich regulates actin remodeling\, membrane trafficking\, and cell spreadin g upon antigen recognition.\n\n \;\n\nDr Yuseff is visiting the Univer sity of Turku for three weeks\, until 18.2. You are welcome to also meet w ith her in person. In such case\, please contact Academy Research Fellow P ieta Mattila (pieta.mattila@utu.fi).\n\n \;\n\nSome of the latest publ ications by Dr Yuseff are listed below:\n\n Ulloa\, R.\, Corrales\, O.\, Cabrera\, F.\, Jara-Wilde\, J.\, Saez\, JJ.\, Rivas\, C.\, Lagos\, J.\, Ha ̈rtel\, S.\, Quiroga\, C.\, Yuseff MI*\, Jheimmy Diaz Muñoz*. B cells a dapt their nuclear morphology to organize the immune synapse and facilitat e antigen extraction.\n Cabrera-Reyes F\, Parra-Ruiz C\, Yuseff MI*\, Zan lungo S*. “Alterations in Lysosome Homeostasis in Lipid-Related Disorder s: Impact on Metabolic Tissues and Immune Cells” Front Cell Dev Biol. 20 21 Dec 10\;9:790568. doi: 10.3389/fcell.2021.790568.\n Ibañez-Vega\, J. \, Del Valle\, F.\, Sáez\, JJ.\, Guzmán\, F.\, Diaz\, J.\, Soza\, A.\, Yuseff\, MI*. “Ecm29-Dependent Proteasome Localization Regulates Cytosk eleton Remodeling at the Immune Synapse” Front Cell Dev Biol. 2021 May 1 3\,9:650817. doi: 10.3389/fcell.2021.650817.\n Sáez\, JJ.\, Diaz\, J.\, Ibañez\, J.\, Bozo\, JP.\, Cabrera\, R.\, Alamo\, M.\, Gobert\, FX.\, O bino\, D\, Bono\, MR.\, Lennon-Duménil\, AM.\, Yeaman\, C and Yuseff. MI . “The exocyst controls lysosome secretion and antigen extraction at the immune synapse of B cells” J Cell Biol. 2019 Jun 13. pii: jcb.201811131 \n Ibañez\, J.\, Del Valle-Batalla\, F.\, Sáez\, JJ.\, Soza\, A. and Yuseff MI. “Proteasome dependent actin remodeling facilitates antigen ex traction at the immune synapse of B cells”. Front Immunol. 2019 Feb 19\; 10:225.\n Obino D\, Fetler L\, Soza A\, Malbec O\, Saez JJ\, Labarca M\, Oyanadel C\, Del Valle Batalla F\, Goles N\, Chikina A\, Lankar D\, Segovi a-Miranda F\, Garcia C\, Léger T\, Gonzalez A\, Espéli M\, Lennon-Dume ́nil AM\, Yuseff MI. "Galectin-8 favors the presentation of surface-tethe red antigens by stabilizing the B cell immune synapse". Cell Rep. 2018 Dec 11\;25(11):3110-3122.e6.\n Obino D\, Diaz J\, Sáez JJ\, Ibañez-Vega J\, Sáez PJ\, Alamo M\, Lankar D\, Yuseff MI. “Vamp-7-dependent secret ion at the immune synapse regulates antigen extraction and presentation in B-lymphocytes”.Mol Biol Cell. 2017.Apr 1\;28(7):890-897.\n END:VEVENT BEGIN:VEVENT UID:148@inflames.utu.fi DTSTART;TZID=Europe/Helsinki:20220301T140000 DTEND;TZID=Europe/Helsinki:20220301T150000 DTSTAMP:20230120T083246Z URL:https://inflames.utu.fi/events/immunology-seminar-heikki-hyoty/ SUMMARY:Immunology Seminar\, Heikki Hyöty DESCRIPTION: \;\n\n\n\nImmunology Seminar\n\nMarch 1st at 14:00 – 15: 00\nVirtual event\n\nHeikki Hyöty\, Tampere University\nType 1 Diabetes\, Enterovirus and Prospects of Vaccine Development\n\nHost: Riitta Lahesmaa (rilahes@utu.fi)\n\nRegistration latest Feb 28 at: https://link.webropols urveys.com/S/64C9EC43374D8B69\nZoom link and iCalendar invitation to join the online event will be sent to all registered participants one day befor e the event.\n\nImmunology seminar series is jointly organised by the Finn ish Society for Immunology\, InFLAMES Flagship and Turku Bioscience. For f urther information contact Anne Lahdenperä (ankahy@utu.fi) or Riitta Lahe smaa (rilahes@utu.fi)\, University of Turku.\n\n \;\n\nDr. Heikki Hyö ty is Professor of Virology at Tampere University\, Faculty of Medicine an d Health Technology since 2013. Prof. Hyöty has received his PhD in virol ogy in 1989. He has served as Professor of Biomedicine and Virology at Uni versity of Tampere prior to his current position. Prof. Hyöty leads a vir ology group that studies the role of viruses and other microbes in immune- mediated diseases including type 1 diabetes\, asthma\, allergy and celiac disease. The group has studied  microbe-disease associations in prospecti ve cohorts and translated innovations to develop new treatments and better diagnostics. One major initiative is the project developing an enteroviru s vaccine that could prevent severe enterovirus diseases and type 1 diabet es. This project has generated a vaccine against Coxsackie B viruses which have been linked to type 1 diabetes.\n\nProfessor Hyöty is coordinator o f four EU funded projects\, and has 422 original articles and altogether n ine patents/patent applications.\n\nSelected publications:\n\n Sioofy-Kho jine AB\, Lehtonen J\, Nurminen N\, Laitinen OH\, Oikarinen S\, Huhtala H\ ,  Pakkanen O\, Ruokoranta T\, Hankaniemi MM\, Toppari J\, Vähä-Mäkil ä M\, Ilonen J\, Veijola R\, Knip M\, Hyöty H. Coxsackievirus B infectio ns are associated with the initiation of insulin-driven autoimmunity that progress to type 1 diabetes. Diabetologia 6:1193-1202\, 2018.\n Hyöty H\ , Leon F\, Knip M. Developing a vaccine for Type 1 diabetes by targeting c oxsackievirus B. Expert Rev Vaccines. 17(12):1071-1083\, 2018.\n Vehik K\ , Lynch KF\, Wong MC\, Tian X\, Ross MC\, Gibbs RA\, Ajami NJ\, Petrosino JF\,  Rewers M\, Toppari J\, Ziegler AG\, She JX\, Lernmark A\, Akolkar B \, Hagopian WA\, Schatz DA\, Krischer JP\, Hyöty H\, Lloyd RE\, and the T EDDY Study Group. Prospective virome analyses reveals prolonged enteroviru s B shedding precedes islet autoimmunity in children at increased genetic risk for type 1 diabetes. Nat Med. 25(12):1865-1872\, 2019.\n Stone VM\, Butrym M\, Hankaniemi MM\, Sioofy-Khojine A-B\, Hytönen VP\, Hyöty H\, F lodström-Tullberg M. Coxsackievirus B vaccines prevent infection-accelera ted diabetes in NOD mice and have no disease-inducing effect. Diabetes 70( 12):2871-2878\, 2021.\n Oikarinen S\, Krogvold L\, Edwin B\, Buanes T\, K orsgren O\, Laiho JE\, Oikarinen M\, Ludvigsson J\, Skog O\, Anagandula M\ , Frisk G\, Hyöty H*\, Dahl-Jørgensen K*. Characterisation of enteroviru s RNA detected in the pancreas and other specimens of live patients with n ewly diagnosed type 1 diabetes in the DiViD study. Diabetologia 64(11):249 1-2501\, 2021.\n END:VEVENT BEGIN:VEVENT UID:137@inflames.utu.fi DTSTART;TZID=Europe/Helsinki:20220311T140000 DTEND;TZID=Europe/Helsinki:20220311T170000 DTSTAMP:20250123T121234Z URL:https://inflames.utu.fi/events/45846/ SUMMARY:2nd InFLAMES Corporate Corner - InFLAMES Ecosystem Services DESCRIPTION:2nd InFLAMES Corporate Corner - InFLAMES Ecosystem Services\nDa te: 11.3.2022\, at 14:00-17:00\nPlace: Presidentti Auritorium\, BioCity\, Tykistökatu 6\, Turku /Zoom: https://utu.zoom.us/j/61111338459\n\nInFLAME S Research Flagship welcomes you to its 2nd Corporate Corner - InFLAMES Ec osystem Services. In this event we want to introduce our high-quality open infrastructure and its benefits to academy-industry collaboration. The go al of the event is to inform you about these unique collaboration opportun ities.\n\nWe are looking forward to meet you in person\, but due to the CO VID-19 situation participation is also possible remotely. All interested p arties are welcome.  A Link to join the online event will be sent to regi stered participants one day before the event.\nRegistration is open! You a re warmly welcome!\nPlease sign up here by March 8th (Registration is clos ed. Please email inflames@utu.fi if you would like to participate onsite.) \n\n \;\nPROGRAMME\n\nInFLAMES Ecosystem Services - How to get access ?\nHost: Professor Juhani Knuuti\, Director of Turku PET Centre\, Universi ty of Turku\n13:45-14:00\nCoffee/Tea\n14:00-14:05\nOpening words\nProfesso r Juhani Knuuti\n14:05-16:30\nTurku PET Centre – Molecular Imaging servi ces\nProfessor Juhani Knuuti\, Turku PET Centre\, University of Turku\n\nT urku Bioscience – Cutting-edge technology at your service\nProfessor Rii tta Lahesmaa\, Turku Bioscience Centre\, University of Turku\n\nCentre for Population Health Research – How to use population cohorts?\nProfessor Linnea Karlsson\, Centre for Population Health Research\n\nCase study: Pre diction and prevention of type 1 diabetes by DIPP study\nProfessor Jorma T oppari\, Institute of Biomedicine\, University of Turku\n\nClinical cancer research – Areas\, possibilities and collaboration\nProfessor Panu Jaak kola\, Western Cancer Center\n\nTurku Center of Disease Modelling – Focu s in advanced animal models\nProfessor Matti Poutanen\, Institute of Biome dicine\, University of Turku\n\nEducation – Come and learn with us!\nDir ector of UTU Graduate School Pirjo Nuutila\,  Director of InFLAMES Doctor al Module Kati Elima\nand Professor Ullamari Pesonen\, Institute of Biomed icine\, Director of DRDP Doctoral programme\n\nClosing words\nProfessor of Practice Timo Veromaa\, University of Turku\n16:30-17:30\nNetworking sess ion with wine and food.\n\n \;\n\nRecording of the event will also be available afterwards.\nYou are warmly welcome! CATEGORIES:Corporate Corner END:VEVENT BEGIN:VEVENT UID:142@inflames.utu.fi DTSTART;TZID=Europe/Helsinki:20220317T120000 DTEND;TZID=Europe/Helsinki:20220317T130000 DTSTAMP:20230120T083246Z URL:https://inflames.utu.fi/events/frontiers-of-science-prof-camille-loch/ SUMMARY:Frontiers of Science: Prof. Camille Locht DESCRIPTION: END:VEVENT BEGIN:VEVENT UID:141@inflames.utu.fi DTSTART;TZID=Europe/Helsinki:20220331T120000 DTEND;TZID=Europe/Helsinki:20220331T130000 DTSTAMP:20230120T083246Z URL:https://inflames.utu.fi/events/frontiers-of-science-prof-hilal-lashuel / SUMMARY:Frontiers of Science: Prof. Hilal Lashuel DESCRIPTION: ATTACH;FMTTYPE=image/jpeg:https://inflames.utu.fi/wp-content/uploads/2022/ 01/lashuel-400px.jpg END:VEVENT BEGIN:VTIMEZONE TZID:Europe/Helsinki X-LIC-LOCATION:Europe/Helsinki BEGIN:STANDARD DTSTART:20201025T030000 TZOFFSETFROM:+0300 TZOFFSETTO:+0200 TZNAME:EET END:STANDARD BEGIN:DAYLIGHT DTSTART:20210328T040000 TZOFFSETFROM:+0200 TZOFFSETTO:+0300 TZNAME:EEST END:DAYLIGHT BEGIN:STANDARD DTSTART:20211031T030000 TZOFFSETFROM:+0300 TZOFFSETTO:+0200 TZNAME:EET END:STANDARD BEGIN:DAYLIGHT DTSTART:20220327T040000 TZOFFSETFROM:+0200 TZOFFSETTO:+0300 TZNAME:EEST END:DAYLIGHT END:VTIMEZONE END:VCALENDAR